| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Science Applications Intl (NASDAQ:SAIC) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 0 | 3 | 0 | 0 |
| Last 30D | 1 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 1 | 0 | 0 |
Analysts have set 12-month price targets for Science Applications Intl, revealing an average target of $116.6, a high estimate of $130.00, and a low estimate of $105.00. Marking an increase of 2.28%, the current average surpasses the previous average price target of $114.00.

An in-depth analysis of recent analyst actions unveils how financial experts perceive Science Applications Intl. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Gavin Parsons | UBS | Lowers | Neutral | $110.00 | $111.00 |
| Jonathan Siegmann | Stifel | Lowers | Buy | $128.00 | $130.00 |
| Tobey Sommer | Truist Securities | Raises | Hold | $110.00 | $100.00 |
| Jonathan Siegmann | Stifel | Announces | Buy | $130.00 | - |
| David Strauss | Barclays | Lowers | Equal-Weight | $105.00 | $115.00 |
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Science Applications Intl's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Science Applications Intl analyst ratings.
Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Science Applications Intl showcased positive performance, achieving a revenue growth rate of 1.62% as of 30 April, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Science Applications Intl's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 3.62%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 4.41%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Science Applications Intl's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.3%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.62, caution is advised due to increased financial risk.
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: SAIC